hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 57 No. 2, 2007.

Izvorni znanstveni članak

Development and in vitro evaluation of buccoadhesive carvedilol tablets

VAMSHI VISHNU YAMSANI
RAMESH GANNU
CHANDRASEKHAR KOLLI
M. E. BHANOJI RAO
MADHUSUDAN RAO YAMSANI

Puni tekst: engleski, pdf (261 KB) str. 185-197 preuzimanja: 999* citiraj
APA 6th Edition
YAMSANI, V.V., GANNU, R., KOLLI, C., RAO, M.E.B. i YAMSANI, M.R. (2007). Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharmaceutica, 57 (2), 185-197. Preuzeto s https://hrcak.srce.hr/9832
MLA 8th Edition
YAMSANI, VAMSHI VISHNU, et al. "Development and in vitro evaluation of buccoadhesive carvedilol tablets." Acta Pharmaceutica, vol. 57, br. 2, 2007, str. 185-197. https://hrcak.srce.hr/9832. Citirano 16.02.2019.
Chicago 17th Edition
YAMSANI, VAMSHI VISHNU, RAMESH GANNU, CHANDRASEKHAR KOLLI, M. E. BHANOJI RAO i MADHUSUDAN RAO YAMSANI. "Development and in vitro evaluation of buccoadhesive carvedilol tablets." Acta Pharmaceutica 57, br. 2 (2007): 185-197. https://hrcak.srce.hr/9832
Harvard
YAMSANI, V.V., et al. (2007). 'Development and in vitro evaluation of buccoadhesive carvedilol tablets', Acta Pharmaceutica, 57(2), str. 185-197. Preuzeto s: https://hrcak.srce.hr/9832 (Datum pristupa: 16.02.2019.)
Vancouver
YAMSANI VV, GANNU R, KOLLI C, RAO MEB, YAMSANI MR. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm. [Internet]. 2007 [pristupljeno 16.02.2019.];57(2):185-197. Dostupno na: https://hrcak.srce.hr/9832
IEEE
V.V. YAMSANI, R. GANNU, C. KOLLI, M.E.B. RAO i M.R. YAMSANI, "Development and in vitro evaluation of buccoadhesive carvedilol tablets", Acta Pharmaceutica, vol.57, br. 2, str. 185-197, 2007. [Online]. Dostupno na: https://hrcak.srce.hr/9832. [Citirano: 16.02.2019.]

Sažetak
Buccoadhesive tablets of carvedilol were prepared using HPMC K4M, HPMC K15M and Carbopol 934 as mucoadhesive polymers. Fifteen formulations were developed with varying concentrations of polymers. Formulations of the BC or BD series were composed of HPMC K4M or HPMC K15M in ratios of 1:1 to 1:5 whereas in the BE series Carbopol 934 was used (1:0.25 to 1:1.50). The formulations were tested for in vitro drug release, in vitro bioadhesion, moisture absorption and in vitro drug permeation through porcine buccal mucosa. Formulation BC3 showed maximum release of the drug (88.7 ± 0.4%) with the Higuchi model release profile and permeated 21.5 ± 2.9% of the drug (flux 8.35 ± 0.291 µg h1cm2) permeation coefficient 1.34 ± 0.05 cm h1) through porcine buccal membrane. BC3 formulation showed 1.62 ± 0.15 N of peak detachment force and 0.24 ± 0.11 mJ of work of adhesion. FTIR results showed no evidence of interaction between the drug and polymers. XRD study revealed that the drug is in crystalline form in the polymer matrix. The results indicate that suitable bioadhesive buccal tablets with desired permeability could be prepared.

Ključne riječi
buccal tablets; carvedilol; formulation; bioadhesion; evaluation

Hrčak ID: 9832

URI
https://hrcak.srce.hr/9832

[hrvatski]

Posjeta: 1.421 *